Advertisement

Regulation of Angiogenesis by Angiotensin II

  • J. Haendeler
  • S. Dimmeler
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 163 / 1)

Abstract

The renin/angiotensin system can exert a double-edged role in angiogenesis signaling. The pro-angiogenic activity of angiotensin II is predominantly mediated by stimulation of the angiotensin II receptor 1 (AT1R), whereas the angiotensin receptor 2 (AT2R) inhibits angiogenesis. The pro-angiogenic activity of angiotensin II is believed to be predominantly mediated by stimulation of VEGF expression. Moreover, a transactivation of the growth promoting epidermal growth factor receptor (EGFR) and the enhanced expression of pro-angiogenic transcription factors such as Cyr61 and Krüppel-like factor may contribute to the pro-angiogenic effects of angiotensin II. In contrast, stimulation of the AT2R inhibits angiogenesis by preventing endothelial cell proliferation and inducing apoptosis of endothelial cells, which counteracts angiogenesis. The apoptosis induction is mediated by an activation of phosphatases and subsequent down-regulation of the anti-apoptotic protein Bcl-2.

Keywords

Angiogenesis Apoptosis Cyr 61 Double-edged role Transactivation VEGF 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aikawa M, Kim HS, et al (1995) Phenotypic modulation of smooth muscle cells during progression of human atherosclerosis as determined by altered expression of myosin heavy chain isoforms. Ann NY Acad Sci 748:578–585PubMedCrossRefGoogle Scholar
  2. Amaral SL, Linderman JR, Morse MM, Greene AS (2001) Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8:57–67PubMedGoogle Scholar
  3. Berk BC (1999) Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. J Am Soc Nephrol 10:S62–S68PubMedGoogle Scholar
  4. Bieker JJ (200l) Kruppel-like factors: three fingers in many pies. J Biol Chem 276:34355–34358Google Scholar
  5. Browder T, Folkman J, Pirie-Shepherd S (2000) The hemostatic system as a regulator of angiogenesis. J Biol Chem 275:1521–1524PubMedCrossRefGoogle Scholar
  6. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395PubMedCrossRefGoogle Scholar
  7. Carmeliet P, Ferreira V, et al (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435–439PubMedCrossRefGoogle Scholar
  8. Dimmeler S, Dernbach E, Zeiher AM (2000) Phosphorylation of the endothelial nitric oxide synthase at Ser 1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477:258–262PubMedCrossRefGoogle Scholar
  9. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM (1997) Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 81:970–976PubMedGoogle Scholar
  10. Dimmeler S, Zeiher AM (2000) Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87:434–439PubMedGoogle Scholar
  11. Fabre JE, Rivard A, Magner M, Silver M, Isner JM(1999) Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 99:3043–3049PubMedGoogle Scholar
  12. Fataccioli V, Abergel V, et al (2002) Stimulation of angiogenesis by cyr61 gene: a new therapeutic candidate. Hum Gene Ther 13:1461–1470PubMedCrossRefGoogle Scholar
  13. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31PubMedCrossRefGoogle Scholar
  14. Fujiyama S, Matsubara H, et al (2001) Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediat-ed EGF receptor transactivation. Circ Res 88:22–29PubMedGoogle Scholar
  15. Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC (2000) Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J Biol Chem 275:15926–15932PubMedCrossRefGoogle Scholar
  16. Hilfiker A, Hilfiker-Kleiner D, et al (2002) Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation 106:254–260PubMedCrossRefGoogle Scholar
  17. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ (1997) Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phophatase-1 and induces apoptosis. J Biol Chem 272:19022–19026PubMedCrossRefGoogle Scholar
  18. Isner JM (2001) Still more debate over VEGF. Nat Med 7:639–641PubMedCrossRefGoogle Scholar
  19. Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231–1236PubMedCrossRefGoogle Scholar
  20. Lastres P, Letamendia A, et al (1996) Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 133:1109–1121PubMedCrossRefGoogle Scholar
  21. Li C, Hampson IN, et al (2000) CD 105 antagonizes the inhibitory signaling of transforming growth factor betal on human vascular endothelial cells. FASEB J 14:55–64PubMedGoogle Scholar
  22. Li D, Chen H, Mehta JL (2001) Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells. Hypertension 38:1062–1067PubMedCrossRefGoogle Scholar
  23. Li DY, Sorensen LK, et al (1999) Defective angiogenesis in mice lacking endoglin. Science 284:1534–1537PubMedCrossRefGoogle Scholar
  24. Macrez-Lepretre N, Kalkbrenner F, Morel JL, Schultz G, Mironneau J (1997) G protein heterotrimer Galphal3betalgamma3 couples the angiotensin AT1A receptor to increases in cytoplasmic Ca2+ in rat portal vein myocytes. J Biol Chem 272:10095–10102PubMedCrossRefGoogle Scholar
  25. Martin MM, White CR, Li H, Miller PJ, Elton TS (1995) A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR). Regul Pept 60:135–147PubMedCrossRefGoogle Scholar
  26. Muramatsu M, Katada J, Hayashi I, Majima M (2000) Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 275:5545–5552PubMedCrossRefGoogle Scholar
  27. Murohara T, Asahara T, et al (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567–2578PubMedCrossRefGoogle Scholar
  28. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233–236PubMedCrossRefGoogle Scholar
  29. Offermanns S, Mancino V, Revel JP, Simon MI (1997) Vascular system defects and impaired cell chemokinesis as a result of Galphal3 deficiency. Science 275:533–536PubMedCrossRefGoogle Scholar
  30. Otani A, Takagi H, Suzuma K, Honda Y (1998) Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82:619–628PubMedGoogle Scholar
  31. Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54:57–79PubMedCrossRefGoogle Scholar
  32. Prenzel N, Zwick E, et al (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884–888PubMedGoogle Scholar
  33. Rao GN, Lassegue B, Alexander RW, Griendling KK (1994) Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth-muscle cells. Biochem J 299:197–201PubMedGoogle Scholar
  34. Richard DE, Berra E, Pouyssegur J (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275:26765–26771PubMedGoogle Scholar
  35. Rössig L, Hermann C, et al (2002) Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apoptosis. Basic Res Cardiol 97:1–8PubMedGoogle Scholar
  36. Sasaki K, Murohara T, et al (2002) Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 109:603–611PubMedGoogle Scholar
  37. Sasaki K, Yamano Y, et al (1991) Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351:230–233PubMedCrossRefGoogle Scholar
  38. Shindo T, Manabe I, et al (2002) Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 8:856–863PubMedGoogle Scholar
  39. Silvestre JS, Tamarat R, et al (2002) Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 90:1072–1079PubMedCrossRefGoogle Scholar
  40. Simon MI, Strathmann MP, Gautam N (1991) Diversity of G proteins in signal transduction. Science 252:802–808PubMedCrossRefGoogle Scholar
  41. Stoll M, Steckelings UM, et al (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95:651–657PubMedCrossRefGoogle Scholar
  42. Tamarat R, Silvestre JS, Durie M, Levy BI (2002) Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor-and inflammation-related pathways. Lab Invest 82:747–756PubMedGoogle Scholar
  43. Tamarat R, Silvestre JS, et al (2002) Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension 39:830–835PubMedCrossRefGoogle Scholar
  44. Unger T, Chung O, et al (1996) Angiotensin receptors. J Hypertens Suppl 14:S95–S103PubMedCrossRefGoogle Scholar
  45. Volpert OV, Ward WF, et al (1996) Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 98:671–679PubMedCrossRefGoogle Scholar
  46. Walsh DA, Hu DE, et al (1997) Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br J Pharmacol 120:1302–1311PubMedCrossRefGoogle Scholar
  47. Williams B, Baker AQ, Gallacher B, Lodwick D (1995) Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25:913–917PubMedGoogle Scholar
  48. Yamada T, Horiuchi M, Dzau VJ (1996) Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci 93:156–160PubMedCrossRefGoogle Scholar
  49. Yoshiji H, Kuriyama S, et al (2001) The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 7:1073–1078PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • J. Haendeler
    • 1
  • S. Dimmeler
    • 1
  1. 1.Molecular Cardiology, Department of Internal Medicine IVUniversity of FrankfurtFrankfurtGermany

Personalised recommendations